Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study.
Yuka AsaiPaul NguyenTimothy P HannaPublished in: PloS one (2021)
A drastic reduction in skin biopsies is noted early in the COVID-19 pandemic; this disproportionately affected the elderly, females and certain geographic regions. Though biopsies subsequently increased, a large backlog of cases remained after almost half a year. This will have implications for downstream care of skin cancer. Efforts should be made to limit diagnostic delay.